Medifast (Medifast) Interest Expense : $0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1981. Start your Free Trial

What is Medifast Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Medifast's interest expense for the three months ended in Mar. 2024 was $ 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $0.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Medifast's Operating Income for the three months ended in Mar. 2024 was $ 7.9 Mil. Medifast's Interest Expense for the three months ended in Mar. 2024 was $ 0.0 Mil. GuruFocus does not calculate Medifast's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medifast Interest Expense Historical Data

The historical data trend for Medifast's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medifast Interest Expense Chart

Medifast Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.23

-0.70

Medifast Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-0.18	-	-	-	-

Medifast Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

Medifast (NYSE:MED) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medifast's Interest Expense for the three months ended in Mar. 2024 was $0.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was $7.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $14.6 Mil.

Medifast's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

GuruFocus does not calculate Medifast's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Medifast Inc has enough cash to cover all of its debt. Its financial situation is stable.

Medifast (Medifast) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Medifast Inc (NYSE:MED) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MED:Mexico MDF:Germany MDF:Germany

Address

100 International Drive, Baltimore, MD, USA, 21202

Website

https://www.medifastinc.com

Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.

Executives

Jeffrey J Brown	director	19900 MACARTHUR BLVD, SUITE 570, IRVINE CA 92612
Andrea B Thomas	director	C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Michael A. Hoer	director	MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Scott Schlackman	director	3600 CRONDALL LANE, OWINGS MILLS MD 21117
Hallquist Constance J.	director	3600 CRONDALL LANE, OWINGS MILLS MD 21117
Elizabeth A. Geary	director	C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Daniel R Chard	director, officer: Chief Executive Officer	NU SKIN ENTERPRISES, INC., 75 WEST CENTER STREET, PROVO UT 84601
Jonathan Barrett Mackenzie	officer: VP, Finance & CAO	100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Kevin G Byrnes	director	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Michael C Macdonald	director	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
James P. Maloney	officer: Chief Financial Officer	415 HOLIDAY DRIVE, PITTSBURGH PA 15220
Ming Xian	director	MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Carl E Sassano	director	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Joseph P Kelleman	officer: (Interim) CFO	3600 CRONDALL LANE, OWINGS MILLS MD 21117
Timothy G Robinson	officer: Chief Financial Officer	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117